Tag Archives: $260

Pharmaceutical companies reach $260 million in opioid case before trial begins

Monday was supposed to be the day when four pharmaceutical companies appeared as defendants in a trial that sought to litigate their culpability in the opioid epidemic. Instead, those companies reached a settlement Monday morning totaling $ 260 million, multiple sources confirm. The four companies in question — AmerisourceBergen Corp., Cardinal Health, McKesson Corp. and… Read More »